Literature DB >> 17632054

Multistep pathogenesis of autoimmune disease.

Christopher C Goodnow1.   

Abstract

In the immune system, many tolerance checkpoints exist to prevent self-antigens from stimulating the relentless growth of self-reactive B and T lymphocytes. The genes and molecular pathways underpinning these checkpoints overlap with those involved in tumor suppression. As with an inherited predisposition to cancer, inherited defects in self-tolerance genes typically precipitate autoimmune disease stochastically after a latent phase. Multiple mutations, inherited and somatic, may be needed before a self-reactive clone bypasses sequential tolerance checkpoints resulting in the emergence of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17632054     DOI: 10.1016/j.cell.2007.06.033

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  151 in total

1.  Loss of c-REL but not NF-κB2 prevents autoimmune disease driven by FasL mutation.

Authors:  L A O'Reilly; P Hughes; A Lin; P Waring; U Siebenlist; R Jain; D H D Gray; S Gerondakis; A Strasser
Journal:  Cell Death Differ       Date:  2014-10-31       Impact factor: 15.828

Review 2.  Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma.

Authors:  Catarina Dias; David A Isenberg
Journal:  Nat Rev Rheumatol       Date:  2011-06       Impact factor: 20.543

3.  Cell type-specific eQTLs in the human immune system.

Authors:  Peter K Gregersen
Journal:  Nat Genet       Date:  2012-04-26       Impact factor: 38.330

4.  Interleukin-10 mediated autoregulation of murine B-1 B-cells and its role in Borrelia hermsii infection.

Authors:  Vishal Sindhava; Michael E Woodman; Brian Stevenson; Subbarao Bondada
Journal:  PLoS One       Date:  2010-07-06       Impact factor: 3.240

5.  microRNAs at the regulatory frontier: an investigation into how microRNAs impact the development and effector functions of CD4 T cells.

Authors:  Erik Allen Lykken; Qi-Jing Li
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 6.  Rethinking mechanisms of autoimmune pathogenesis.

Authors:  Shiv Pillai
Journal:  J Autoimmun       Date:  2013-06-25       Impact factor: 7.094

Review 7.  MicroRNA control of B cell tolerance, autoimmunity and cancer.

Authors:  Changchun Xiao; David Nemazee; Alicia Gonzalez-Martin
Journal:  Semin Cancer Biol       Date:  2020-08       Impact factor: 15.707

Review 8.  MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases.

Authors:  Rujuan Dai; S Ansar Ahmed
Journal:  Transl Res       Date:  2011-02-01       Impact factor: 7.012

9.  Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation.

Authors:  Aude Magerus-Chatinet; Bénédicte Neven; Marie-Claude Stolzenberg; Cécile Daussy; Peter D Arkwright; Nina Lanzarotti; Catherine Schaffner; Sophie Cluet-Dennetiere; Filomeen Haerynck; Gérard Michel; Christine Bole-Feysot; Mohammed Zarhrate; Isabelle Radford-Weiss; Serge P Romana; Capucine Picard; Alain Fischer; Frédéric Rieux-Laucat
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

10.  LYN- and AIRE-mediated tolerance checkpoint defects synergize to trigger organ-specific autoimmunity.

Authors:  Irina Proekt; Corey N Miller; Marion Jeanne; Kayla J Fasano; James J Moon; Clifford A Lowell; Douglas B Gould; Mark S Anderson; Anthony L DeFranco
Journal:  J Clin Invest       Date:  2016-08-29       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.